The US approved a drug for rare childhood epilepsy

Belgian biotech company UCB SA has announced that the US Food and Drug Administration (FDA) has approved its drug for the treatment of seizures associated with Lennox-Gastaut syndrome (LSG), a rare form of childhood epilepsy.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner